These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17562816)

  • 1. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
    Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
    J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity in hyper-IgM syndrome.
    Jesus AA; Duarte AJ; Oliveira JB
    J Clin Immunol; 2008 May; 28 Suppl 1():S62-6. PubMed ID: 18246414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
    Yoon SH; Cho HI; Kim TG
    Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.
    Shoker AS; Lun ZR; Choudry R; Saxena A
    Transpl Immunol; 2001 Feb; 8(4):219-28. PubMed ID: 11316064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
    Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
    Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
    Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
    Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.
    Cicalese MP; Gerosa J; Baronio M; Montin D; Licciardi F; Soresina A; Dellepiane RM; Miano M; Baselli LA; Volpi S; Dufour C; Plebani A; Aiuti A; Lougaris V; Fousteri G
    Front Immunol; 2018; 9():1761. PubMed ID: 30131802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of somatic hypermutations in the IgM switch region in human B cells.
    Horiuchi K; Imai K; Mitsui-Sekinaka K; Yeh TW; Ochs HD; Durandy A; Nonoyama S
    J Allergy Clin Immunol; 2014 Aug; 134(2):411-9. PubMed ID: 24836470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
    Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
    J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
    Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
    J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
    Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
    J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
    Sacco MG; Ungari M; Catò EM; Villa A; Strina D; Notarangelo LD; Jonkers J; Zecca L; Facchetti F; Vezzoni P
    Cancer Gene Ther; 2000 Oct; 7(10):1299-306. PubMed ID: 11059686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
    Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
    Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of enteric IgA in an unimmunised mouse model of Hyper IgM syndrome derived from gut-associated secondary lymph organs even in the absence of germinal centres.
    Hernandez-Cazares F; Maqueda-Alfaro RA; Lopez-Saucedo C; Martinez-Barnetche J; Yam-Puc JC; Estrada-Parra S; Flores-Romo L; Estrada-Garcia T
    Front Cell Infect Microbiol; 2023; 13():1172021. PubMed ID: 37457961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.